Drug
Oravescent Fentanyl
Oravescent Fentanyl: highest development phase Phase 3, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| OraVescent Fentanyl NCT00228605 | Phase 3 | Low Back Pain |
Latest
No recent events.
Follow Oravescent Fentanyl on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.